Year: 2025

LAS VEGAS, Dec. 10, 2025 (GLOBE NEWSWIRE) — GBank Financial Holdings Inc. (the “Company”) (Nasdaq: GBFH), the parent company of GBank (the “Bank”), is pleased to announce two important approvals impacting its strategic partner BoltBetz. First, BoltBetz has received approval from the Nevada Gaming Control Board (“GCB”) as a software solution that allows players to create and fund a wagering account in Konami’s SYNKROS cashless wagering system via the BoltBetz mobile app. Second, Distill and Remedy’s Taverns have received GCB approval to use the BoltBetz product as approved by the GCB Lab. The Distill approval acknowledged that since GBank will be holding all funds – and not Distill or BoltBetz – a digital fund reserve is not required. Todd Nigro, BoltBetz co-founder and CEO, stated, “After many years of planning and...

STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has dosed the first patient in the phase 2a clinical study of sevuparin as a potential new treatment for chronic kidney disease with anemia. The study is conducted in Italy and will evaluate the safety and efficacy of sevuparin in repeated dosing. Modus Therapeutics, listed on Nasdaq First North Growth Market, announces that the first patient has been dosed in the second part of its ongoing phase 2a clinical study, in which sevuparin is evaluated as a new treatment for chronic kidney disease with anemia, and thus follows the company’s previously communicated timetable. The first part of the phase 2a study was completed in July and showed that sevuparin was well tolerated and provided...

SAN MATEO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis Pharma Inc. issued a December 10 statement that China’s National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for denifanstat for the treatment of moderate to severe acne. Sagimet has granted an exclusive license to denifanstat for China to Ascletis Bioscience Co. Ltd. (Ascletis), of which Ascletis Pharma Inc. is the parent company. Denifanstat is a once-daily oral small molecule fatty acid synthase (FASN) inhibitor being developed by Ascletis for acne in China as ASC40, and by Sagimet for metabolic dysfunction associated steatohepatitis (MASH)...

Major new brand campaign developed with Colin Jost’s No Notes Productions lampoons bad tech and champions the employees who suffer for it SAN JOSE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Today, on behalf of employees everywhere, Zoom announced the launch of a major brand campaign developed with Colin Jost’s No Notes Productions lampooning the technology everybody hates and inspiring users to stand up for what they really want. Starring SNL standout Bowen Yang, the “Zoom Ahead” campaign will debut on December 31 during the U.S. College Football Playoffs with the hero spot, I Use Zoom!, which taps into a universal truth — people just want technology that works for them. The campaign will continue with additional high-profile placements, including a Super Bowl pre-show placement on February 8, and will be supported by digital, social,...

Pharma Equity Group executes on the Company’s new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S Copenhagen, 10 December 2025 Company Announcement no. 15 Pharma Equity Group A/S (“PEG”) today announces that the company has signed a Letter of Intent regarding the acquisition of the entire share capital or a majority stake in Otiom A/S. The transaction marks the first concrete step in PEG’s expanded strategy to become a leading consolidator within Life Science, spanning Pharma, MedTech, and other health related technologies. Strategic Rationale: From Vision to Action In line with the Company’s newly published strategy, PEG focuses on identifying and scaling Nordic innovation companies that solve significant unmet medical needs. Otiom A/S fits strongly into this strategic framework....

IRVINE, CA., Dec. 10, 2025 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy technology company delivering scalable solutions in power generation, storage, waste-to-energy, and heat-to-power, today announced a dedicated HTAP™ based platform designed for integration with existing and planned anaerobic digestion (AD) and renewable natural gas (RNG) facilities. The solution enables AD operators to convert hard-to-digest biomass and AD digestate into additional renewable energy and carbon-rich biochar, improving the overall efficiency and economics of RNG production. Many AD plants face biogas-output limitations due to the low biodegradability of certain organic feedstocks. CETY’s High Temperature Ablative Pyrolysis (HTAP™) technology thermochemically converts...

KYND cyber intelligence integrates into Verisk’s Rulebook, as new KYND research reveals 80 percent of the UK’s top retailers are vulnerable to cyber threats LONDON, Dec. 10, 2025 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, announced today an expansion of its strategic collaboration with KYND to bring enriched cyber risk intelligence to the insurance market. KYND’s cyber risk insights are now integrated into Verisk’s Rulebook platform, which supports pricing, underwriting and distribution services for all major classes of business. By combining Verisk’s global insurance expertise with KYND’s advanced cyber intelligence, this product integration provides insurers and brokers with seamless access to actionable intelligence, enabling more informed...

Award-winning Iris datalink service is paving the way to trajectory-based operations, which can cut emissions and enhance efficiency for European airlines ROME, Dec. 10, 2025 (GLOBE NEWSWIRE) — Viasat Inc., a global leader in satellite communications, today announced that ITA Airways, Italy’s reference carrier, is taking to the sky equipped with Iris technology. The award-winning European Space Agency (ESA) Iris programme, within ESA Connectivity and Secure Communications, is led by Viasat and takes advantage of next-generation satellite technologies to help modernize Air Traffic Management (ATM). The service is underpinned by Iris Service Provider and key project partner ESSP, who holds the EASA certification for Iris services provision and has onboarded 19 leading Air Navigation Service Providers (ANSPs) for the Pre-commercial...